Xreal Sues Viture Over Smart Glasses Patent Infringement
Chinese AR glasses maker Xreal files lawsuit against competitor Viture in Texas federal court, alleging patent infringement on key technologies ahead of Apple's expected market entry.
Category : Search result: Revlimid patent
Pharma Q3 Preview: India Growth Offsets Revlimid Pain
Indian pharma companies face margin pressure from Revlimid patent expiry and US competition, but strong domestic sales and core business momentum may cushion the blow in Q3 FY26.
McConaughey Files Voice & Image with US Patent Office Against AI
Oscar-winning actor Matthew McConaughey has registered his voice and image with US patent authorities to prevent unauthorized AI use. His legal team explains this proactive move aims to protect his identity and capture value from new technology.
Patents Slow Innovation in Fast-Moving Tech Sectors
Patent laws designed for slower eras now hinder progress as AI accelerates discovery. Historical examples show how extended monopolies block innovation.
Delhi HC Allows Zydus to Sell Cheaper Cancer Drug Biosimilar
Delhi High Court overturns injunction, allowing Zydus Lifesciences to manufacture and sell biosimilar of Nivolumab, making cancer treatment 70% cheaper in India.
Delhi HC Permits Zydus to Sell Cancer Drug Biosimilar
Delhi High Court permits Zydus Lifesciences to sell its biosimilar of cancer drug Nivolumab until patent expiry in May 2026. Court mandates detailed sales records to protect innovator Squibb's interests. Read more.
AI Tool Unlocks Patent Research, Saves R&D Time
Perplexity Patents, an AI-powered tool, helps innovation teams validate ideas and explore patent landscapes using natural language, preventing costly late-stage discoveries. Discover how it streamlines R&D.
MIMS Files 6 AI Medical Patents for Cancer Surgery
Mandya Institute of Medical Sciences announces 6 joint patent applications for AI-driven cancer detection tech, marking a major step in establishing a Medical AI & Robotics hub in Karnataka. Discover the breakthrough.
Natco Pharma Sues to Revoke Novo Nordisk's Semaglutide Patent
Natco Pharma files suit in Delhi High Court seeking revocation of Novo Nordisk's patent on diabetes drug semaglutide. Court issues notice, hearing set for Feb 5. Indian pharma race for generic Ozempic heats up.
KGMU-IIT Kanpur get patent for wearable breast sensor
SIB SHInE at KGMU, with IIT-Kanpur, patents a wearable sensor for early breast abnormality detection. A breakthrough in med-tech innovation. Read about the collaborative triumph.
PU's Robotic Lawn Mower Gets Patent for Grass Printing
Panjab University's Design Innovation Centre receives an Indian patent for its 'Grass Printer' robot. This autonomous machine can cut grass at varying heights to print messages, symbols, and intricate designs on large lawns, revolutionizing automated land
Why Indian Drug Makers Challenge Global Patents
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Natco Files to Revoke Novo Nordisk's Wegovy Patent in India
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Ex-Minister Prabhu Lal Saini Patents 3 Date Palm Varieties
Former Rajasthan agriculture minister Prabhu Lal Saini secures patents for three indigenous date palm varieties, ST-1, ST-2, and ST-3, boosting local cultivation. Discover his 10-year research journey.
PAU Gets Patent for Rodent Contraceptive Bait
Punjab Agricultural University patents a groundbreaking contraceptive bait for rodents, offering a humane and effective solution to protect crops and public health. Learn about this innovative pest control method.
Generic Semaglutide to Create Rs 50,000 Cr Market
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Generic Semaglutide to Create Rs 50bn+ Revenue Opportunity
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
Semaglutide Patent Expiry Creates Rs 50,000 Cr Opportunity
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
Why the Safety Pin Has a Hole: A 175-Year-Old Design Secret
Discover the engineering marvel behind the tiny hole in every safety pin. From Walter Hunt's 1849 patent to modern uses, learn how this simple feature ensures durability and function.
IIT Jodhpur files record 86 IPRs in 2025
IIT Jodhpur achieves a milestone with 86 IPR filings in 2025, marking a 150% growth. The patents focus on affordable, sustainable tech for national priorities. Discover the institute's innovation drive.
Indian Pharma Firms Eye Licensing Deals for Obesity Drugs
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
MGU Kottayam gets patent for AI driver fatigue detection system
Mahatma Gandhi University patents an AI-powered drowsiness detection system developed by Prof. Pushpalatha K P & Vineetha Vijayan. It aims to slash road accidents via real-time alerts. Read more.
MSU's Modular Toddler Play Station Wins Design Patent
Maharaja Sayajirao University's innovative 'Play Station for Toddlers' transforms into regular furniture. This modular, Montessori-inspired design promotes learning and safety. Read more about this patented innovation.
Sanskriti University Rank 6 in India for Patent Filings
Sanskriti University in Mathura achieves All India Rank 6 for patent filings, reinforcing its commitment to research and innovation. Discover how it's shaping future innovators.
Hexaware moves to dismiss $500 million US patent lawsuit
Hexaware Technologies seeks dismissal of a $500 million patent infringement suit filed by Natsoft, arguing the patents cover abstract ideas, not genuine inventions. The outcome could significantly impact the IT firm's finances.
Cusat Gets Patent for Digital Evidence Fingerprint Tech
Cochin University researchers patent a system to create tamper-proof digital fingerprints for evidence, boosting forensic reliability for law enforcement. Read more about this innovation.
Bangladesh Beats India to Export Weight-Loss Drugs to Emerging Markets
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Court sets interim royalty rate at $0.365 per device
London High Court grants Acer, Asus, and Hisense an interim license to use Nokia's video patents. Judge sets royalty at $0.365 per device, a middle ground in the FRAND dispute. Nokia plans to appeal. Read the full details.
India's Patent Filings Cross 1 Lakh, Domestic Share at 62%
India's patent applications crossed 1.1 lakh in FY25, a 20% jump, with domestic innovators driving 62% of filings. IPR growth signals a robust R&D surge. Read more.
National Patent for Ladakh's Wastewater Hydroponic Farming
Govind Ballabh Pant Institute's Ladakh centre patents a hydroponic system using treated wastewater, boosting food security in fragile Himalayan ecosystems. Read about this climate-smart breakthrough.
Page 1 of 2